iiinova — where your digital self keeps evolving

Cathy Pogson @cathypogson.bsky.social · 19/08/2025

Registration is open for the Dialysis Academy 2025. 18-19th September 2025 @ Royal Pharmaceutical Society in London In person or virtual gbr01.safelinks.protection.outlook.com?url=https%3A...

020

Cathy Pogson @cathypogson.bsky.social · 23/05/2025

📣 Pharmacist-led research opportunity Do you have a kidney research idea or project or know a kidney-pharmacist looking for funding? @kidneyresearchuk.org are opening pharmacist-led research grants on Monday 25th May 2025

000

Cathy Pogson @cathypogson.bsky.social · 11/05/2025

Fabulous couple of days @cpcongress.bsky.social presenting my present bpspubs.onlinelibrary.wiley.com/doi/10.1111/... and future research plans www.kidneyresearchuk.org/2025/04/22/p... & with UK Renal Pharmacy preventing progression to end stage kidney disease @kidneyresearchuk.org @ukkidney.org

043

Cathy Pogson @cathypogson.bsky.social · 25/04/2025

🥳 🥳 My research continues ⬇️ ⬇️ www.kidneyresearchuk.org/2025/04/22/p... 📣Thank you @kidneyresearchuk.org @pharmacyresearchuk.org @ukkidney.org

141

Reposted by Cathy Pogson

Peritoneal Dialysis International Journal @pdi-journal.bsky.social · 16/03/2025

**March 2025 Issue** #EditorsChoice Articles #OpenAccess 📄 : Impact of frailty on mortality and transfer to hemodialysis after peritoneal dialysis initiation 👥:Sophie Gaube et al @ispd1 @pd_perls journals.sagepub.com/doi/pdf/10.1...

1104

Cathy Pogson @cathypogson.bsky.social · 11/03/2025

Thank you @kidneyresearchuk.org for a fabulous day listening to inspiring researchers.

121

Reposted by Cathy Pogson

NIHR ARC Wessex @arcwessex.bsky.social · 14/02/2025

De-prescribing for people with #MCI Mild cognitive impairment. The STOP-DEM project produced a toolkit to help www.arc-wx.nihr.ac.uk/research-are... @nihrarcs.bsky.social @unisouthampton.bsky.social @pcpa-uk.bsky.social @stephenlim.bsky.social @gerisoc.bsky.social @uhsft.bsky.social #polypharmacy

21914

Reposted by Cathy Pogson

Eric Topol @erictopol.bsky.social · 13/02/2025

How do GLP-1 drugs affect cognitive and mental health disorders? A comprehensive review www.nature.com/articles/s44...

Evidence based on the literature for various traits and disorders

1320343

Reposted by Cathy Pogson

Jane Shanahan @janeshanahan.bsky.social · 16/01/2025

This study highlighted that anticholinergic and sedative medications to avoid in older people are still frequently prescribed despite the development and regular updating of potentially inappropriate medication criteria agsjournals.onlinelibrary.wiley.com/doi/10.1111/...

agsjournals.onlinelibrary.wiley.com

Assessing the prevalence of anticholinergic and sedative medications to avoid in older adults from the French Health Data System

Background In older people, medications with anticholinergic or sedative properties are associated with falls, frailty, and functional and cognitive impairment. These medications are often described.....

1138

Reposted by Cathy Pogson

UK Kidney Association @ukkidney.org · 17/01/2025

🎖️Let's celebrate exceptional individuals in kidney-related healthcare during 2025🎖️ We are seeking nominations for these awards: 🎖️King's Honours ow.ly/krrt50UFflM 🌟UKKA Named Lectures ow.ly/BMT450UFf60 🏆UKKA Lifetime Achievement 📧a 100-word statement to ukka@ukkidney.org by 27 January

001

Cathy Pogson @cathypogson.bsky.social · 03/01/2025

Thank you for highlighting our research

011

Cathy Pogson @cathypogson.bsky.social · 31/12/2024

📣 A new paper: Medication review interventions for adults living with advanced chronic kidney disease; a scoping review ➡️ doi.org/10.1111/bcp.... Identifies a clear gap in the care of people living with chronic kidney illness

doi.org

BPS Publications

Structured medication reviews (SMRs) were introduced into the National Health Service (NHS) Primary Care to support the delivery of the NHS Long-Term Plan for medicines optimization. SMRs improve the...

1103